Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Pfizer To Stop New Clinical Trials In Russia: Reuters

Reuters reported that Pfizer Inc (NYSE:PFE) said it would not run any new clinical trials in Russia and would stop recruiting for existing trials there.

Pfizer said it would work with the FDA and other regulators to transition all clinical trials to alternative sites outside Russia. It will continue providing drugs to the patients already enrolled in studies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.